Pharming Group N.V. (PHAR)
NASDAQ: PHAR · Real-Time Price · USD
17.21
-0.46 (-2.60%)
At close: Jan 2, 2026, 4:00 PM EST
17.14
-0.07 (-0.41%)
After-hours: Jan 2, 2026, 4:10 PM EST
Pharming Group Market Cap
Pharming Group has a market cap or net worth of $1.18 billion as of January 2, 2026. Its market cap has increased by 95.29% in one year.
Market Cap
1.18B
Enterprise Value
1.14B
1-Year Change
95.29%
Ranking
Category
Stock Price
$17.21
Market Cap Chart
Since June 16, 1999, Pharming Group's market cap has increased from $128.85M to $1.18B, an increase of 813.68%. That is a compound annual growth rate of 8.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 1.15B | 76.58% |
| Dec 31, 2024 | 649.63M | -14.84% |
| Dec 29, 2023 | 762.86M | 0.93% |
| Dec 30, 2022 | 755.82M | 32.18% |
| Dec 31, 2021 | 571.80M | -42.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 962.25B |
| Johnson & Johnson | 498.60B |
| AbbVie | 403.83B |
| UnitedHealth Group | 299.03B |
| AstraZeneca | 287.81B |
| Novartis AG | 266.00B |
| Merck & Co. | 261.26B |
| Novo Nordisk | 227.63B |